openPR Logo
Press release

Track Valsartan Price Report Historical and Forecast

11-24-2025 06:17 AM CET | Health & Medicine

Press release from: ChemAnalyst

Executive Summary

The global Valsartan market experienced a period of measured volatility from late 2024 through Q3 2025, influenced by shifting inventory cycles, tariff transitions, freight disruptions, and evolving procurement behavior across key pharmaceutical markets. North America, APAC, and Europe each displayed distinct price trajectories shaped by tariff policies, logistical congestion, manufacturing sentiment, and strategic inventory decisions.

By Q3 2025, Valsartan prices softened across all major regions, driven by rising inventories, improved freight conditions, and buyer hesitation associated with tariff and policy uncertainties. Subdued demand, combined with reduced spot activity, exerted downward pressure on market indices even as production cost trends stabilized.

Despite interim softness, the medium-term outlook suggests mild recovery potential as inventories normalize and strategic restocking resumes. With shifting trade flows, tariff-driven procurement cycles, and volatile freight dynamics, Valsartan remains a procurement-sensitive pharmaceutical product requiring close monitoring of global supply-chain variables.

This comprehensive report provides a PR-ready analysis of global Valsartan pricing, regional market behavior, quarterly movements, cost structures, historical insights, demand-supply dynamics, and forward-looking procurement considerations.

◼ Get Instant Access to Live Valsartan Prices Today: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Valsartan

Introduction

Valsartan, an essential antihypertensive active pharmaceutical ingredient (API), continues to play a vital role in both generic and branded formulations of cardiovascular therapeutics worldwide. As a high-volume API with complex manufacturing steps and multi-tiered supply chains, its pricing is highly responsive to geopolitics, logistics, import policies, raw material availability, and inventory cycles.

The period spanning Q4 2024 to Q3 2025 marked substantial shifts in the global Valsartan market. Factors such as tariff impositions and suspensions in the United States, export competitiveness in China, production stabilization in major pharmaceutical hubs, and ongoing freight disruptions in Europe collectively shaped market sentiment.

Inventory management became a pivotal driver of pricing across all regions as distributors increasingly adopted cautious procurement strategies in the face of volatile macroeconomic signals. Freight rates, port congestion, and rerouting of shipments further influenced landed costs and price movements.

This PR-style article provides a holistic, structured evaluation of the Valsartan market, building on the extensive data you provided.

Global Valsartan Price Overview

The global Valsartan market experienced softening price momentum through Q3 2025, as all major regions reported quarter-over-quarter declines due to destocking, subdued buying interest, and easing logistics.

A snapshot:

North America (USA): Q3 2025 Valsartan Price Index declined 2.44%, with average prices near USD 79,546.67/MT.
APAC (China): Q3 2025 Price Index declined 2.397%, with a quarterly average of USD 79,400.00/MT.
Europe (Germany): Q3 2025 Price Index declined 2.41%, averaging USD 79,511.67/MT.
These coordinated declines reflect a synchronized pullback in global procurement activity, driven by excess inventories, improved shipping conditions, and delayed buying amid tariff and geopolitical uncertainties.

Earlier quarters showed sharper fluctuations, especially in Q2 2025, as tariff suspensions, shipping bottlenecks, and inventory realignments significantly impacted month-to-month pricing behavior.

Overall, global prices have remained range-bound but sensitive to shifts in trade policies and freight costs. A mild stabilization is expected moving into late Q4 2025, contingent on inventory digestion and return of normal procurement cycles.

◼ Monitor Real-Time Valsartan Price Swings and Stay Ahead of Competitors: https://www.chemanalyst.com/Pricing-data/valsartan-1406

Detailed Regional Analysis

North America Market Analysis

Q3 2025 Market Behavior

The U.S. Valsartan market in Q3 2025 was characterized by inventory-driven softness, with prices falling 2.44% QoQ. Key factors included:

Destocking pressures following earlier frontloaded imports.
Weak Valsartan demand as buyers delayed purchases amid tariff uncertainty and cautious healthcare procurement strategies.
Improved logistics, resulting in falling freight rates and easing landed costs.
Discount-heavy spot market activity as distributors sought to clear excess inventory.
The average quarterly price was USD 79,546.67/MT, reflecting subdued transactional activity and limited pricing power for sellers.

Why Prices Declined in September 2025 (North America)

Excess inventories from earlier stockpiling reduced buying urgency.
Lower freight costs allowed sellers to discount more aggressively.
Tariff uncertainty led to delayed procurement cycles.
Distributor undercutting created competitive downward price pressure.
Balanced stock levels limited scope for any rebound.

◼ Track Daily Valsartan Price Updates and Strengthen Your Procurement Decisions: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Valsartan

Q2 2025: Tariff, Freight, and Demand-Driven Volatility

North America experienced one of the most volatile quarters during Q2 2025, with month-to-month fluctuations:

April -0.99%: High 145% tariffs on Chinese imports caused cost absorption and inventory buildup.
May +3.15%: Temporary 90-day tariff suspension triggered heavy procurement and freight strain.
June -1.05%: Buyers paused activity amid tariff uncertainty and oversupply.

Drivers included:

Frontloaded imports ahead of tariff changes.
Port congestion, equipment shortages, and elevated shipping rates.
Oscillating procurement behavior as buyers adopted a "wait-and-watch" stance.

Q1 2025: Pre-Tariff Stockpiling and Stabilization

The initial quarter saw moderate fluctuations:

January: Prices climbed due to anticipated tariffs and potential ILA strike.
February: Prices softened as supply improved after Lunar New Year.
March: Prices rose slightly (0.09%) driven by early procurement ahead of tariff announcements.
Cost Structure and Procurement Behavior

Tariff policies became the largest cost variable, influencing landed costs more than production inputs.
Logistics volatility-especially GRI, PSS, and equipment shortages-affected short-term pricing.
Buyers shifted toward shorter contract cycles and flexible procurement patterns.
Inventory management became strategic, with distributors aiming to prevent overstocking.

APAC Market Analysis (China)

Q3 2025 Market Behavior

APAC markets, particularly China, saw a 2.397% QoQ decline in the Valsartan Price Index. The average price remained around USD 79,400.00/MT.

Market conditions included:

Muted export demand, as global buyers chose inventory drawdown over new contracts.
Aggressive exporter discounts to boost offtake amid rising domestic inventories.
Weak Spot Price activity influenced by logistics delays and subdued global procurement.
Stable production but limited pricing power due to falling PPI and ample stock availability.

Why Prices Declined in September 2025 (APAC)

Buyers globally continued inventory consumption instead of fresh sourcing.
Falling freight costs and removal of surcharges strengthened buyer leverage.
Competitive export environment forced Chinese suppliers to reduce offers.
Logistics delays and port disruptions pushed sellers to prioritize stock clearance.

Q2 2025: Tariff Reprieve and Demand Cycles

April -0.99%: Weak global demand and overstocking cut prices.
May +3.13%: U.S. tariff suspension drove strong export orders.
June -1.15%: Overcapacity and soft global demand pressured prices again.
China's PMI dropping to 49.0 in April highlighted manufacturing slowdown, contributing to weak API demand.

◼ Unlock Live Pricing Dashboards for Accurate and Timely Insights: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Valsartan

A YoY 3.6% decline in China's PPI further reduced input costs, limiting producer pricing power.

Q1 2025: Tight Supply and Rising Prices

Q1 was relatively bullish in China:

January: Seasonal output slowdowns and tariff-driven export rush lifted prices.
February: Lunar New Year reduced production; demand remained steady.
March: Early procurement ahead of expected tariffs kept prices firm.
The region's rising inventories through mid-2025 set the stage for Q3's downward trajectory.

Europe Market Analysis (Germany)

Q3 2025 Market Behavior

Europe mirrored global trends with a 2.41% QoQ decline in the Germany Price Index, averaging USD 79,511.67/MT.

Key contributors:

High inventory levels, reducing procurement urgency.
Soft Spot Prices compared to contracts due to oversupply.
Cost-stable environment, supported by subdued freight and feedstock variables.
Export pressure from Asia, intensifying competitive pricing.
Staggered distributor stock clearance dampened market sentiment.
Why Prices Declined in September 2025 (Europe)

Elevated inventory and cautious procurement suppressed spot activity.
Port congestion and deferred PSS prevented freight inflation, limiting upward price movement.
Chinese exporters increased offers into Europe as U.S. tariffs redirected flows.
Weak downstream demand created a buyer's market.

Q2 2025: Procurement Cycles and Logistics Bottlenecks

April -0.99%: Oversupply from U.S. tariff-driven diversion.
May +3.12%: Port congestion and vessel shortages tightened supply.
June -0.99%: Buyers focused on clearing stock; delayed PSS stabilized freight.
Europe, especially German ports, faced persistent logistical challenges, though cost escalation was mitigated through carrier deferrals.

Q1 2025: Demand Oscillations and Logistic Disruptions

January: Business sentiment and healthcare demand lifted prices.
February: Inventory saturation and stronger Euro reduced prices.
March: Port congestion and labor unrest led to slight rebounds.

Q4 2024: Inflation, Logistics, and Currency Pressures

Germany's Valsartan market experienced:

October: Higher prices supported by improved sentiment and ECB rate cuts.
November: Lower demand and falling energy costs softened prices.
December: Inventory clearance and weak consumer confidence pushed prices down.
Across these quarters, Valsartan pricing behavior clearly reflected the interplay between tariff regimes, logistical bottlenecks, inventory cycles, and downstream pharmaceutical demand.

Production and Cost Structure Insights

Stable feedstock availability during Q3 2025 helped maintain predictable production costs.
Declining freight rates, particularly after mid-2025, softened landed cost pressures globally.
China's falling PPI enabled lower marginal costs for producers, translating into competitive export pricing.
U.S. tariff volatility remained the single most significant cost factor for North American importers.
Overall, production-side cost inflation was limited throughout 2025, with logistics being the primary cost variable.

Procurement Outlook

Moving into late Q4 2025 and early 2026:

Mild recovery is expected as inventories normalize.
Buyers may resume contractual procurement after prolonged market hesitation.
Tariff clarity will play a decisive role in the U.S. purchasing landscape.
Competitive export offerings from China will continue influencing European and U.S. price behavior.
Freight stabilization supports predictable landed cost expectations.
Healthcare sector demand remains steady but cautious.
Procurement teams should remain agile, monitoring:

Policy changes (tariffs, surcharges)
Freight market signals
Supplier inventory disclosures
Export order flow from China
Regional production restarts or shutdowns

◼ Stay Updated Each Day with Verified Valsartan Price Movements: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Valsartan

Frequently Asked Questions (FAQ)

Why did Valsartan prices fall in Q3 2025 globally?
Excess inventories, subdued procurement, declining freight costs, and improved logistics collectively reduced pricing momentum across all major markets.

What were the key factors influencing North American prices?
Tariff uncertainty, improved freight availability, and heavy destocking drove U.S. price declines.

Why did China experience consistent downward pressure?
Weak export demand, high inventory, declining PPI, and aggressive discounting limited price support.

How did Europe respond to shifting global trade flows?
Europe absorbed excess Asian supply resulting from U.S. tariffs, contributing to oversupply and softer pricing.

Will Valsartan prices recover in late 2025?
A modest recovery is possible as inventories normalize and buying cycles resume.

How ChemAnalyst Supports Buyers

ChemAnalyst empowers procurement teams, manufacturers, and strategic decision-makers with real-time market intelligence, including:

Live price updates for 450+ chemicals and APIs
Weekly pricing trends and market commentary
Tariff, trade-flow, and logistics impact analysis
Forecast models integrating economic, supply-chain, and demand indicators
Supply disruption tracking, including plant outages and freight constraints
Global presence across major ports-Houston, Shanghai, Antwerp, Busan, Rotterdam, Hamburg, and more
Expert analysts with backgrounds in chemical engineering, economics, and supply-chain management
Buyers rely on ChemAnalyst to make informed procurement decisions, optimize timing, and mitigate risk in an increasingly complex pharmaceutical supply chain.

Contact Us:

UNITED STATES

Call +1 3322586602

420 Lexington Avenue, Suite 300, New York, NY,

United States, 10170

Germany

Call +49-221-6505-8833

S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Website: https://www.chemanalyst.com/

About Us:

Welcome to ChemAnalyst, a next-generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as "Product Innovator of the Year 2023" and ranked among the "Top 100 Digital Procurement Solutions Companies," we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Track Valsartan Price Report Historical and Forecast here

News-ID: 4283882 • Views:

More Releases from ChemAnalyst

Track Amlodipine Besylate Price Index Historical and Forecast
Track Amlodipine Besylate Price Index Historical and Forecast
Executive Summary The global Amlodipine Besylate market has experienced significant fluctuations from Q4 2024 through Q3 2025, influenced by shifting trade policies, logistics constraints, evolving pharmaceutical demand, geopolitical developments, and seasonal restocking cycles. Prices increased modestly in Q3 2025 across major regions-North America, APAC, and Europe-primarily driven by importer frontloading, logistics bottlenecks, and higher freight rates. However, earlier quarters exhibited strong volatility, including sharp declines in Q2 2025 due to excess
Track Rifaximin Price Trend Historical and Forecast
Track Rifaximin Price Trend Historical and Forecast
Executive Summary The global Rifaximin market has demonstrated a pattern of marginal yet meaningful fluctuations across 2024 and 2025, shaped by tariff policies, freight dynamics, inventory cycles, and evolving healthcare sector demand. Across North America, APAC, and Europe, Rifaximin prices have reacted to a mixture of external shocks-ranging from U.S.-China tariff rounds to port congestion, labor unrest, seasonal production shifts, and backlogged inventories. While the Quarter Ending September 2025 saw a
Track Poly Methyl Methacrylate (PMMA) Price Trend Historical and Forecast
Track Poly Methyl Methacrylate (PMMA) Price Trend Historical and Forecast
Executive Summary The global Poly Methyl Methacrylate (PMMA) market has experienced a period of moderated pricing, shaped by evolving demand patterns across key end-use sectors, shifting feedstock Methyl Methacrylate (MMA) costs, steady production dynamics, and region-specific logistical and procurement factors. For the quarter ending September 2025, PMMA prices trended softer across major regions-North America, APAC, and Europe-as automotive demand showed weakness, electronics procurement followed just-in-time strategies, and balanced inventories prevailed. While upstream
Track Paraxylene Price Index Historical and Forecast
Track Paraxylene Price Index Historical and Forecast
Executive Summary The global Paraxylene (PX) market experienced a series of complex movements across 2024 and 2025, shaped by shifting feedstock fundamentals, downstream consumption patterns, macroeconomic headwinds, supply chain adjustments, and regional trade variations. As a core feedstock for the production of PTA and PET resins, paraxylene remains sensitive to volatility in crude oil, naphtha, and polyester value-chain demand. Across North America, APAC, and Europe, the September 2025 quarter illustrated how

All 5 Releases


More Releases for Valsartan

Valsartan Manufacturing Plant Setup Report 2025: Cost Analysis and Investment Op …
Valsartan is a prescription medication belonging to the class of angiotensin II receptor blockers (ARBs). It is primarily used to treat high blood pressure (hypertension), heart failure, and to improve survival after a heart attack. By blocking the effects of angiotensin II, it relaxes blood vessels, reducing blood pressure and easing the heart's workload. Valsartan is widely prescribed due to its effectiveness and relatively low side-effect profile compared to older
Sacubitril Valsartan Sodium Market Key Players, Share and Forecast Outlook
"The global market for Sacubitril Valsartan Sodium, a critical medication for heart failure and related cardiovascular conditions, is valued at approximately $4.2 billion in 2024. Projections indicate a substantial growth trajectory, with an anticipated market value reaching around $7.5 billion by 2034. This reflects a robust Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period from 2025 to 2034." Exactitude Consultancy., Ltd. released a research report titled "Sacubitril Valsartan
Sacubitril Valsartan Sodium Market Key Players, Share and Forecast Outlook
"The global market for Sacubitril Valsartan Sodium, a critical medication for heart failure and related cardiovascular conditions, is valued at approximately $4.2 billion in 2024. Projections indicate a substantial growth trajectory, with an anticipated market value reaching around $7.5 billion by 2034. This reflects a robust Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period from 2025 to 2034." Exactitude Consultancy., Ltd. released a research report titled "Sacubitril Valsartan
Valsartan Drug Market Size and Forecast
Valsartan Drug Market size was valued at USD 31.76 Billion in 2023 and is expected to reach USD 43.18 Billion by the end of 2030 with a CAGR of 4.1% During the Forecast Period 2024-2030. Valsartan Drug Market Outlook and Investment Analysis What is the current outlook for the Valsartan drug market? The Valsartan drug market is experiencing growth driven by the increasing prevalence of hypertension and cardiovascular diseases globally. Valsartan, an angiotensin
Valsartan Manufacturing Plant Project Report 2023, Operating Costs and Profit Pr …
IMARC Group's report titled "Valsartan Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a valsartan manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the
Valsartan Tablets Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION offers a latest published report on Valsartan Tablets Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This intelligence Valsartan Tablets Market report by LP INFORMATION includes investigations based on the current scenarios, historical records, and future predictions. An accurate data of various aspects such as type, size, application, and end user have been scrutinized in this research report.